Characterization of liposarcoma cell lines for preclinical and biological studies

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Stratford, Eva W ^a   Castro, Russell ^a   Daffinrud, Jeanette ^b   Skårn, Magne ^a   Lauvrak, Silje ^a   Munthe, Else ^a   Myklebost, Ola ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPOSARCOMA; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 84864931514     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/148614     Document Type: Article

References (63)

1. Conyers R., Young S., Thomas D. M., Liposarcoma: molecular genetics and therapeutics Sarcoma 2011 2011 13
2. Henricks W. H., Chu Y. C., Goldblum J. R., Weiss S. W., Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation American Journal of Surgical Pathology 1997 21 3 271 281 (Pubitemid 27120195)
3. McCormick D., Mentzel T., Beham A., Fletcher C. D. M., Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas American Journal of Surgical Pathology 1994 18 12 1213 1223 (Pubitemid 24362434)
4. Singer S., Antonescu C. R., Riedel E., Brennan M. F., Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma Annals of Surgery 2003 238 3 358 371 (Pubitemid 38174479)
5. Pedeutour F., Forus A., Coindre J. M., Berner J. M., Nicolo G., Michiels J. F., Terrier P., Ranchere-Vince D., Collin F., Myklebost O., Turc-Carel C., Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors Genes Chromosomes Cancer 1999 24 1 30 41 (Pubitemid 28544460)
6. Rosai J., Akerman M., Dal Cin P., DeWever I., Fletcher C. D. M., Mandahl N., Mertens F., Mitelman F., Rydholm A., Sciot R., Tallini G., van den Berghe H., van de Ven W., Vanni R., Willen H., Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP study group) American Journal of Surgical Pathology 1996 20 10 1182 1189 (Pubitemid 26336841)
7. Nishio J., Iwasaki H., Ishiguro M., Ohjimi Y., Fujita C., Ikegami H., Ariyoshi A., Naito M., Kaneko Y., Kikuchi M., Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization International Journal of Oncology 2003 22 3 535 542
8. Persson F., Olofsson A., Sjgren H., Chebbo N., Nilsson B., Stenman G., man P., Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line Cancer Letters 2008 260 1-2 37 47
9. Snyder E. L., Sandstrom D. J., Law K., Fiore C., Sicinska E., Brito J., Bailey D., Fletcher J. A., Loda M., Rodig S. J., Dal Cin P., Fletcher C. D. M., c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme Journal of Pathology 2009 218 3 292 300
10. Wabitsch M., Brderlein S., Melzner I., Braun M., Mechtersheimer G., Mller P., LiSa-2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation International Journal of Cancer 2000 88 6 889 894
11. Peng T., Zhang P., Liu J., Nguyen T., Bolshakov S., Belousov R., Young E. D., Wang X., Brewer K., Lpez-Terrada D. H., Oliveira A. M., Lazar A. J., Lev D., An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors Laboratory Investigation 2011 91 3 392 403
12. Mills J., Matos T., Charytonowicz E., Hricik T., Castillo-Martin M., Remotti F., Lee F. Y., Matushansky I., Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo Human Cell 2009 22 4 85 93
13. Kresse S. H., Meza-Zepeda L. A., Machado I., Llombart-Bosch A., Myklebost O., Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations Cancer 2011 118 2 558 570
14. Skarn M., Namlos H. M., Noordhuis P., Wang M. Y., Meza-Zepeda L. A., Myklebost O., Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by MicroRNA-155, MicroRNA-221, and MicroRNA-222 Stem cells development 864 1 1 52
15. Freytag S. O., Paielli D. L., Gilbert J. D., Ectopic expression of the CCAAT/enhancer-binding protein promotes the adipogenic program in a variety of mouse fibroblastic cells Genes and Development 1994 8 14 1654 1663 (Pubitemid 24236244)
16. Tontonoz P., Hu E., Spiegelman B. M., Stimulation of adipogenesis in fibroblasts by PPAR 2, a lipid-activated transcription factor Cell 1994 79 7 1147 1156
17. Tontonoz P., Singer S., Forman B. M., Sarraf P., Fletcher J. A., Fletcher C. D. M., Brun R. P., Mueller E., Altiok S., Oppenheim H., Evans R. M., Spiegelman B. M., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor and the retinoid X receptor Proceedings of the National Academy of Sciences of the United States of America 1997 94 1 237 241 (Pubitemid 27027193)
18. Wu Z., Xie Y., Bucher N. L. R., Farmer S. R., Conditional ectopic expression of C/EBP in NIH-3T3 cells induces PPAR and stimulates adipogenesis Genes Development 1995 9 19 2350 2363
19. Bernlohr D. A., Coe N. R., LiCata V. J., Fatty acid trafficking in the adipocyte Seminars in Cell Developmental Biology 1999 10 1 43 49 (Pubitemid 129505537)
20. Ambrosini G., Sambol E. B., Carvajal D., Vassilev L. T., Singer S., Schwartz G. K., Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1 Oncogene 2007 26 24 3473 3481 (Pubitemid 46816754)
21. Mller C. R., Paulsen E. B., Noordhuis P., Pedeutour F., Ster G., Myklebost O., Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A International Journal of Cancer 2007 121 1 199 205 (Pubitemid 46753868)
22. Singer S., Socci N. D., Ambrosini G., Sambol E., Decarolis P., Wu Y., O'Connor R., Maki R., Viale A., Sander C., Schwartz G. K., Antonescu C. R., Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma Cancer Research 2007 67 14 6626 6636 (Pubitemid 47105508)
23. Shoemaker R. H., The NCI60 human tumour cell line anticancer drug screen Nature Reviews Cancer 2006 6 10 813 823 (Pubitemid 44450469)
24. Stinson S. F., Alley M. C., Kopp W. C., Fiebig H. H., Mullendore L. A., Pittman A. F., Kenney S., Keller J., Boyd M. R., Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen Anticancer Research 1992 12 4 1035 1053
25. Balke M., Neumann A., Kersting C., Agelopoulos K., Gebert C., Gosheger G., Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane BMC Research Notes 2010 3, article 58
26. Mohseny A. B., MacHado I., Cai Y., Schaefer K.-L., Serra M., Hogendoorn P. C. W., Llombart-Bosch A., Cleton-Jansen A.-M., Functional characterization of osteosarcoma cell lines provides representative models to study the human disease Laboratory Investigation 2011 91 8 1195 1205
27. Ottaviano L., Schaefer K. L., Gajewski M., Huckenbeck W., Baldus S., Rogel U., Mackintosh C., De Alava E., Myklebost O., Kresse S. H., Meza-Zepeda L. A., Serra M., Cleton-Jansen A. M., Hogendoorn P. C. W., Buerger H., Aigner T., Gabbert H. E., Poremba C., Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort Genes Chromosomes Cancer 2010 49 1 40 51
28. Quintana E., Shackleton M., Sabel M. S., Fullen D. R., Johnson T. M., Morrison S. J., Efficient tumour formation by single human melanoma cells Nature 2008 456 7222 593 598
29. Ben-Porath I., Thomson M. W., Carey V. J., Ge R., Bell G. W., Regev A., Weinberg R. A., An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nature Genetics 2008 40 5 499 507 (Pubitemid 351601215)
30. Brune J. C., Tormin A., Johansson M. C., Rissler P., Brosj O., Lfvenberg R., von Steyern F. V., Mertens F., Rydholm A., Scheding S., Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts International Journal of Cancer 2011 129 2 319 330
31. Chamberlain G., Fox J., Ashton B., Middleton J., Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing Stem Cells 2007 25 11 2739 2749 (Pubitemid 350127858)
32. Park P. C., Selvarajah S., Bayani J., Zielenska M., Squire J. A., Stem cell enrichment approaches Seminars in Cancer Biology 2007 17 3 257 264 (Pubitemid 46415738)
33. Stratford E., Castro R., Wennerstrom A., Holm R., Munthe E., Lauvrak S., Bjerkehagen B., Myklebost O., Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential Clinical Sarcoma Research 2011 1 1, article 8
34. Yang Z. F., Ho D. W., Ng M. N., Lau C. K., Yu W. C., Ngai P., Chu P. W. K., Lam C. T., Poon R. T. P., Fan S. T., Significance of CD90 + cancer stem cells in human liver cancer Cancer Cell 2008 13 2 153 166 (Pubitemid 351163165)
35. Tirino V., Desiderio V., Paino F., De Rosa A., Papaccio F., Fazioli F., Pirozzi G., Papaccio G., Human primary bone sarcomas contain CD133 + cancer stem cells displaying high tumorigenicity in vivo The FASEB Journal 2011 25 6 2022 2030
36. Pérez-Gmez E., Del Castillo G., Juan Francisco S., Lpez-Novoa J. M., Bernabéu C., Quintanilla M., The role of the TGF- coreceptor endoglin in cancer TheScientificWorldJournal 2010 10 2367 2384
37. Henry L. A., Johnson D. A., Sarri D., Lee S., Quinlan P. R., Crook T., Thompson A. M., Reis-Filho J. S., Isacke C. M., Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome Oncogene 2011 30 9 1046 1058
38. Pardali E., van der Schaft D. W. J., Wiercinska E., Gorter A., Hogendoorn P. C. W., Griffioen A. W., Ten Dijke P., Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma Oncogene 2011 30 3 334 345
39. Levings P. P., McGarry S. V., Currie T. P., Nickerson D. M., McClellan S., Ghivizzani S. C., Steindler D. A., Gibbs C. P., Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma Cancer Research 2009 69 14 5648 5655
40. Jin D., Fan J., Wang L., Thompson L. F., Liu A., Daniel B. J., Shin T., Curiel T. J., Zhang B., CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression Cancer Research 2010 70 6 2245 2255
41. Sadej R., Spychala J., Skladanowski A. C., Ecto-5′-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells Nucleosides, Nucleotides Nucleic Acids 2006 25 911 1119 1123 (Pubitemid 44651858)
42. Spychala J., Lazarowski E., Ostapkowicz A., Ayscue L. H., Jin A., Mitchell B. S., Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer Clinical Cancer Research 2004 10 2 708 717 (Pubitemid 38174010)
43. Wang L., Zhou X., Zhou T., Ma D., Chen S., Zhi X., Yin L., Shao Z., Ou Z., Zhou P., Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells Journal of Cancer Research and Clinical Oncology 2008 134 3 365 372 (Pubitemid 351170058)
44. Gibbs C. P., Kukekov V. G., Reith J. D., Tchigrinova O., Suslov O. N., Scott E. W., Ghivizzani S. C., Ignatova T. N., Steindler D. A., Stem-like cells in bone sarcomas: implications for tumorigenesis Neoplasia 2005 7 11 967 976
45. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 (Pubitemid 36418143)
46. Chu P., Clanton D. J., Snipas T. S., Julia L., Mitchell E., Nguyen M. L., Hare E., Peach R. J., Characterization of a subpopulation of colon cancer cells with stem cell-like properties International Journal of Cancer 2009 124 6 1312 1321
47. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M. A., Daidone M. G., Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Research 2005 65 13 5506 5511 (Pubitemid 40911148)
48. Zhu Z., Hao X., Yan M., Yao M., Ge C., Gu J., Li J., Cancer stem/progenitor cells are highly enriched in CD133 + CD44 + population in hepatocellular carcinoma International Journal of Cancer 2010 126 9 2067 2078
49. Klarmann G. J., Hurt E. M., Mathews L. A., Zhang X., Duhagon M. A., Mistree T., Thomas S. B., Farrar W. L., Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature Clinical Experimental Metastasis 2009 26 5 433 446
50. Ginestier C., Hur M. H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C. G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M. S., Dontu G., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 2007 1 5 555 567 (Pubitemid 350056407)
51. Hermann P. C., Huber S. L., Herrler T., Aicher A., Ellwart J. W., Guba M., Bruns C. J., Heeschen C., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 2007 1 3 313 323 (Pubitemid 47355323)
52. Ma S., Chan K. W., Hu L., Lee T. K., Wo J. Y., Ng I. O., Zheng B. J., Guan X. Y., Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 2007 132 7 2542 2556 (Pubitemid 46890873)
53. O'Brien C. A., Pollett A., Gallinger S., Dick J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 2007 445 7123 106 110 (Pubitemid 46067310)
54. Ricci-Vitiani L., Lombardi D. G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R., Identification and expansion of human colon-cancer-initiating cells Nature 2007 445 7123 111 115 (Pubitemid 46067311)
55. Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors Cancer Research 2003 63 18 5821 5828 (Pubitemid 37187480)
56. Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B., Identification of human brain tumour initiating cells Nature 2004 432 7015 396 401 (Pubitemid 39551674)
57. Walter D., Satheesha S., Albrecht P., Bornhauser B. C., D'Alessandro V., Oesch S. M., Rehrauer H., Leuschner I., Koscielniak E., Gengler C., Moch H., Bernasconi M., Niggli F. K., Schfer B. W., CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres PLoS One 2011 6 5
58. Huang E. H., Hynes M. J., Zhang T., Ginestier C., Dontu G., Appelman H., Fields J. Z., Wicha M. S., Boman B. M., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Research 2009 69 8 3382 3389
59. Ma S., Kwok W. C., Lee T. K. W., Kwan H. T., Wo J. Y. H., Zheng B. J., Guan X. Y., Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations Molecular Cancer Research 2008 6 7 1146 1153
60. Ran D., Schubert M., Pietsch L., Taubert I., Wuchter P., Eckstein V., Bruckner T., Zoeller M., Ho A. D., Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes Experimental Hematology 2009 37 12 1423 1434
61. Su Y., Qiu Q., Zhang X., Jiang Z., Leng Q., Liu Z., Stass S. A., Jiang F., Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer Cancer Epidemiology Biomarkers and Prevention 2010 19 2 327 337
62. Kryczek I., Liu S., Roh M., Vatan L., Szeliga W., Wei S., Banerjee M., Mao Y., Kotarski J., Wicha M. S., Liu R., Zou W., Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells International Journal of Cancer 2011 130 1 29 39
63. Silva I. A., Bai S., McLean K., Yang K., Griffith K., Thomas D., Ginestier C., Johnston C., Kueck A., Reynolds R. K., Wicha M. S., Buckanovich R. J., Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Research 2011 71 11 3991 4001